Search
for
Sort by
Research 31–60 of 1000+
- Women's midlife health Reframing menopause
- THE IMPACT OF LIFESTYLE: THE EFFECTS OF DIET, EXERCISE AND INOSITOL SUPPLEMENTATION ON THE COURSE OF POLYENDOCRINE METABOLIC OVARIAN SYNDROME (PMOS): NARRATIVE REVIEW
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- Serum Cystatin C levels in adolescent females: A comparative study between PCOS and Non-PCOS groups
- Polycystic ovary syndrome
- ANTI-MÜLLERIAN HORMONE LEVEL AS A PREDICTIVE FACTOR IN THE DIAGNOSIS OF POLYCYSTIC OVARIAN SYNDROME IN DUHOK PROVINCE – KURDISTAN REGION, IRAQ
- The Effects of FemmeBalance Supplement on Symptoms of Premenstrual Syndrome: A Four-Cycle Single-Arm Observational Study of a Novel Nutritional Supplement
- POLİKİSTİK OVER SENDROMU'NUN ALT GRUPLARINDA METABOLİK ÖZELLİKLER
- Polycystic ovary syndrome (PCOS)
- Disorders of ovulation
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- Is 3α, 17β-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
- Comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndrome
- Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
- Menopause
- POLYCYSTIC OVARY SYNDROME (PCOS)–AN OVERVIEW
- Polycystic ovarian disease in adult and perimenopausal women
- Hirsutism in Polycystic Ovary Syndrome: Pathophysiology and Management
- Oral Contraceptives and Cyproterone Acetate in Female Acne Treatment
- Complications of Subcutaneous Contraception: A Review
- Immediate and Delayed Complications of Dexamethasone Cyclophosphamide Pulse (DCP) Therapy
- The frequency of polycystic ovary syndrome in females with resistant acne vulgaris
- The treatment of polycystic ovary syndrome.
- Contraceptive Implants
- Diagnosing polycystic ovary syndrome
- Hirsutism and baldness
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Study of the Prevalence of Different Causes of Hair Loss among Females with Polycystic Ovary Syndrome in Delta Area-Egypt
- Serum Anti-Müllerian Hormone as a Predictor of Polycystic Ovarian Syndrome among Women of Reproductive Age
- Лечебный эффект спиронолактона при синдроме гиперандрогении